Solazyme (SZYM) Misses Q3 EPS by 3c

Solazyme (NASDAQ: SZYM) reported Q3 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $17.6 million versus the consensus estimate of $19.5 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance